Prothena Corporation plc [NASDAQ: PRTA] plunged by -$0.73 during the normal trading session on while it closed the day at $7.35.
Prothena Corporation plc stock has also loss -24.15% of its value over the past 7 days. However, PRTA stock has declined by -49.28% in the 3 months of the year. Over the past six months meanwhile, it has lost -56.76% and lost -46.93% year-on date.
The market cap for PRTA stock reached $395.63 million, with 53.83 million shares outstanding and 47.13 million shares in the current float. Compared to the average trading volume of 647.44K shares, PRTA reached a trading volume of 4149614 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Prothena Corporation plc [PRTA]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PRTA shares is $51.75 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PRTA stock is a recommendation set at 1.40. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Chardan Capital Markets have made an estimate for Prothena Corporation plc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on December 20, 2024. While these analysts kept the previous recommendation, BofA Securities dropped their target price from $68 to $38. The new note on the price target was released on January 30, 2024, representing the official price target for Prothena Corporation plc stock. Previously, the target price had yet another raise to $62, while Deutsche Bank analysts kept a Buy rating on PRTA stock.
The Average True Range (ATR) for Prothena Corporation plc is set at 0.78, with the Price to Sales ratio for PRTA stock in the period of the last 12 months amounting to 2.93. The Price to Book ratio for the last quarter was 0.81, with the Price to Cash per share for the same quarter was set at 8.76.
PRTA stock trade performance evaluation
Prothena Corporation plc [PRTA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -24.15. With this latest performance, PRTA shares dropped by -32.32% in over the last four-week period, additionally sinking by -56.76% over the last 6 months – not to mention a drop of -66.65% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PRTA stock in for the last two-week period is set at 18.82, with the RSI for the last a single of trading hit 12.40, and the three-weeks RSI is set at 24.36 for Prothena Corporation plc [PRTA]. The present Moving Average for the last 50 days of trading for this stock 11.85, while it was recorded at 8.37 for the last single week of trading, and 15.98 for the last 200 days.
Prothena Corporation plc [PRTA]: An insightful look at the core fundamentals
Prothena Corporation plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.01 and a Current Ratio set at 10.01.
Earnings per share (EPS) analysis for Prothena Corporation plc [PRTA] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PRTA. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Prothena Corporation plc go to -15.39%.
Prothena Corporation plc [PRTA]: Institutional Ownership
The top three institutional holders of PRTA stocks are: ECOR1 CAPITAL, LLC with ownership of 11.58 million shares, which is approximately 21.5453%. FMR LLC, holding 8.07 million shares of the stock with an approximate value of $$166.48 million in PRTA stocks shares; and FMR LLC, currently with $$87.46 million in PRTA stock with ownership which is approximately 7.881%.
